Key clinical point: Use of intrauterine contraceptive devices was safe and effective for patients aged 22 years and younger with physical, intellectual, and developmental disabilities.
Major finding: The IUD continuation rate was 95% after 1 year and 73% after 5 years.
Study details: The data come from a retrospective study of 159 patients aged 22 years and younger with disabilities who received 185 levonorgestrel IUDs.
Disclosures: The study was supported by a Bayer Healthcare Investigator-Initiated Research grant for women’s health to Dr. Schwartz and coauthor Lesley L. Breech, MD. The researchers had no other financial conflicts to disclose.
Schwartz BI et al. Pediatrics. 2020 Jul 23. doi: 10.1542/peds.2020-0016.